<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJPed</journal-id><journal-title-group><journal-title>Open Journal of Pediatrics</journal-title></journal-title-group><issn pub-type="epub">2160-8741</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojped.2021.114069</article-id><article-id pub-id-type="publisher-id">OJPed-113773</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Factors Affecting the Developmental Outcomes of High-Risk Newborns
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jiranun</surname><given-names>Weerakul</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mattayan</surname><given-names>Sanjaiban</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Suneera</surname><given-names>Intasen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Pediatrics Department, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand</addr-line></aff><pub-date pub-type="epub"><day>29</day><month>09</month><year>2021</year></pub-date><volume>11</volume><issue>04</issue><fpage>749</fpage><lpage>758</lpage><history><date date-type="received"><day>4,</day>	<month>November</month>	<year>2021</year></date><date date-type="rev-recd"><day>7,</day>	<month>December</month>	<year>2021</year>	</date><date date-type="accepted"><day>10,</day>	<month>December</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background:
   Newborns weighing less than 2,500 grams and those with birth asphyxia are particularly vulnerable to multiple complications. This study aimed to evaluate the prevalence and factors related to developmental delays in high-risk newborns. <b>Methods: </b>This study included the clinical data of infants with a birth weight of under 2500 grams or an Apgar score of less than 7 at 1 or 5 minutes after birth. Medical records from January 1, 2015 to December 31, 2020 were included. The actual age of the infants was corrected according to gestational age. Participants with genetic abnormalities (trisomy 21, 18, 13) and congenital brain anomalies (hydrocephalus, encephalocele) were excluded. The Developmental Assessment for Intervention Manual (DAIM) was used during follow-up visits. Multivariate logistic regression analysis was used to examine the data. <b>Results: </b>Of the 297 patients included, 110 completed the follow-up and 62 infants (56%) had developmental delays. Significant associations with delayed development included maternal age (adjusted odds ratio [AOR]
   
  3.36, 95% confidence interval [CI] 1.19
   - 
  9.46), male sex (AOR 3.23, 95% CI 1.24
   - 
  8.44), gestational age below 32 weeks (AOR 33.35, 95% CI 1.39
   - 
  799.87), and neonatal hypoglycemia (AOR 3.81, 95% CI 1.13
   - 
  12.85). <b>Conclusion:</b> Maternal age, male sex, gestational age less than 32 weeks, and neonatal hypoglycemia were all associated risk factors for developmental delays in high-risk infants.
 
</p></abstract><kwd-group><kwd>Birth Asphyxia</kwd><kwd> Low Birth Weight</kwd><kwd> Neurodevelopmental Outcome</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Low birth weight is defined by the World Health Organization (WHO) as a pediatric condition in which a newborn weighs between 1500 and 2499 grams. An infant born weighing between 1000 and 1499 grams is known as a very low birth weight infant, and a newborn with a birth weight of 999 grams or less is considered an extremely low birth weight infant. An Apgar score of 4 - 7 at 5 minutes after birth indicates mild to moderate birth asphyxia, while an Apgar score of 0 - 3 indicates severe birth asphyxia [<xref ref-type="bibr" rid="scirp.113773-ref1">1</xref>]. Low birth weight and birth asphyxia are common occurrences in newborns worldwide, with a prevalence of 15.5% and 15.9%, respectively [<xref ref-type="bibr" rid="scirp.113773-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref3">3</xref>]. Today, medical technology has advanced to a point where the survival rate of premature infants has improved considerably, particularly those with extremely low birth weight. Lower gestational age, especially below 25 weeks, results in more severe impairment in the infants [<xref ref-type="bibr" rid="scirp.113773-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref5">5</xref>]. Prompt intervention by medical professionals reduces the risk of long-term complications. Respiratory distress syndrome and sepsis are the most common complications in preterm births [<xref ref-type="bibr" rid="scirp.113773-ref6">6</xref>]. Premature infants can develop bronchopulmonary dysplasia, retinopathy of prematurity, developmental delays, and other long-term complications [<xref ref-type="bibr" rid="scirp.113773-ref7">7</xref>]. Furthermore, newborns weighing less than 2500 grams and those with hypoxic-ischemic encephalopathy are particularly vulnerable to developmental delays [<xref ref-type="bibr" rid="scirp.113773-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref9">9</xref>]. In Thailand, the incidence of birth asphyxia is 90.2 - 100.7 per 1000 live births [<xref ref-type="bibr" rid="scirp.113773-ref10">10</xref>]. According to the WHO, neonatal deaths resulting from birth asphyxia account for 29% of all neonatal deaths globally [<xref ref-type="bibr" rid="scirp.113773-ref11">11</xref>]. In Thailand, the Developmental Assessment for Intervention Manual (DAIM) was implemented in 2015, and the development of high-risk newborns was followed up on a regular basis.</p><p>This study aimed to determine the prevalence of low birth weight and birth asphyxia in newborns, as well as the correlating factors that contribute to developmental delays.</p></sec><sec id="s2"><title>2. Methods</title><p>The Institutional Review Board (IRB No. 0007/63) of Medicine Faculty of Naresuan University approved the study. The requirement for informed consent was waived by the ethics committee due to the retrospective nature of the study. De-identified data were collected for this cross-sectional analytical study from inpatient and outpatient records at our hospital. The inclusion criteria were as follows: patients with a birth weight of less than 2500 grams or an Apgar score of less than 7 at 1 or 5 minutes after birth from 1 January 2015 to 31 December 2020. Exclusion criteria included newborns with genetic abnormalities (trisomy 21, 18, 13) and congenital brain anomalies (hydrocephalus, encephalocele). The inpatient data of the newborns came from the prenatal, perinatal, postnatal, and maternal records, and the outpatient data came from their developmental records using the Developmental Assessment for Intervention Manual (DAIM). The DAIM is a nationwide developmental screening tool for high-risk infants and includes advice and videos that parents can use to encourage their child’s development. According to DAIM, the high-risk newborns mean the newborn weighs under 2500 grams and Apgar score of less than 7 at 1 or 5 minutes. The Thai Child Development Integrated Committee developed the DAIM in 2015. It consists of 122 items in five domains: 1) gross motor skills, 2) fine motor skills, 3) receptive language skills, 4) expressive language skills, and 5) personal and social skills. It also consists of five items on neurodevelopment. DAIM was shown to achieve a sensitivity and specificity of 85.7% and 86.3%, respectively for assessment of infant development delay [<xref ref-type="bibr" rid="scirp.113773-ref12">12</xref>]. Corrected age was calculated prior to the developmental assessment if the newborn's gestational age was less than 37 weeks.</p><p>A follow-up assessment of the infants was conducted every 2 months in the first 6 months, then every 3 months until 2 years of age, and if their development was abnormal, they were advised to start a program of early stimulation by a caregiver at home for a month. The developmental stimulation program included instructions and videos to encourage development. The infants were then re-evaluated for development. If delayed development persisted, the infants were referred for additional development stimulation from healthcare personnel.</p><p>Statistical analysis</p><p>Data entry and analyses were performed using Stata12.1 (College Station, Texas 77845 USA). The demographic data are expressed as percentages. Logistic regression was used to calculate the odds ratio (OR) for the association between factors and delayed development. The adjusted OR (AOR) was calculated using multiple logistic regression with a 95% confidence interval (CI) and according to a significance level of p &lt; 0.05.</p></sec><sec id="s3"><title>3. Results</title><p>The data of 297 newborns were included in this study. The data of 16 newborns were excluded because of Down syndrome, brain anomalies, and referral to other hospitals resulting in incomplete data for the developmental assessment. In addition, 171 newborns had incomplete follow-up data. Thus, the data of 110 newborns were analyzed, of which 62 were found to have developmental delays (56%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Among the 110 high-risk newborns included in the study, 62 were female (56.4%), 61 had a gestational age between 32 and 37 weeks (55.5%), 86 weighed between 1501 and 2499 grams (78.2%), 2 had an Apgar score less than 7 at 1 and 5 minutes after birth (1.8%), 44 stayed in the hospital for 1 - 7 days (length of stay [LOS]) (40%), and 79 were not intubated (71.8%). Seventy neonates had mothers above 20 years of age (63.1%). Most of the mothers (n = 87, 89.1%) had an uncomplicated delivery (possible complications included gestational diabetes, preeclampsia, and intrauterine infection) (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Sixty-two of the 110 newborns (56.4%) had developmental delays; 35 of these 62 (56.5%) newborns had only one developmental delay out of the five domains, while the remainder had multiple developmental delays. The most common developmental delays were noted in gross motor skills (n = 52, 47.3%), expressive language skills (n = 24, 21.8%), and receptive language skills (n = 16, 14.5%) (<xref ref-type="table" rid="table2">Table 2</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Demographical data of the neonates and mothers</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Data</th><th align="center" valign="middle"  colspan="2"  >Number (n = 110)</th><th align="center" valign="middle"  colspan="2"  >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle"  colspan="2"  >48</td><td align="center" valign="middle"  colspan="2"  >43.6</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle"  colspan="2"  >62</td><td align="center" valign="middle"  colspan="2"  >56.4</td></tr><tr><td align="center" valign="middle" >Gestational age (weeks)</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >&lt;25</td><td align="center" valign="middle"  colspan="2"  >2</td><td align="center" valign="middle"  colspan="2"  >1.8</td></tr><tr><td align="center" valign="middle" >25 - 32</td><td align="center" valign="middle"  colspan="2"  >17</td><td align="center" valign="middle"  colspan="2"  >15.5</td></tr><tr><td align="center" valign="middle" >32 - 37</td><td align="center" valign="middle"  colspan="2"  >61</td><td align="center" valign="middle"  colspan="2"  >55.5</td></tr><tr><td align="center" valign="middle" >37 - 42</td><td align="center" valign="middle"  colspan="2"  >30</td><td align="center" valign="middle"  colspan="2"  >27.2</td></tr><tr><td align="center" valign="middle" >Birth weight (g)</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >&lt;1000</td><td align="center" valign="middle"  colspan="2"  >9</td><td align="center" valign="middle"  colspan="2"  >8.2</td></tr><tr><td align="center" valign="middle" >1000 - 1499</td><td align="center" valign="middle"  colspan="2"  >15</td><td align="center" valign="middle"  colspan="2"  >13.6</td></tr><tr><td align="center" valign="middle" >1500 - 2499</td><td align="center" valign="middle"  colspan="2"  >86</td><td align="center" valign="middle"  colspan="2"  >78.2</td></tr><tr><td align="center" valign="middle" >2500 - 3799</td><td align="center" valign="middle"  colspan="2"  >0</td><td align="center" valign="middle"  colspan="2"  >0.0</td></tr><tr><td align="center" valign="middle" >≥3800</td><td align="center" valign="middle"  colspan="2"  >0</td><td align="center" valign="middle"  colspan="2"  >0.0</td></tr><tr><td align="center" valign="middle" >Apgar score at 1 minute &lt; 7</td><td align="center" valign="middle"  colspan="2"  >22</td><td align="center" valign="middle"  colspan="2"  >20.0</td></tr><tr><td align="center" valign="middle" >at 1 and 5 minutes &lt; 7</td><td align="center" valign="middle"  colspan="2"  >2</td><td align="center" valign="middle"  colspan="2"  >1.8</td></tr><tr><td align="center" valign="middle" >Twin</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle"  colspan="2"  >36</td><td align="center" valign="middle"  colspan="2"  >32.7</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle"  colspan="2"  >74</td><td align="center" valign="middle"  colspan="2"  >67.3</td></tr><tr><td align="center" valign="middle" >Length of hospital stay</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >1 - 7 days</td><td align="center" valign="middle" >44</td><td align="center" valign="middle"  colspan="2"  >40.0</td></tr><tr><td align="center" valign="middle" >7 days - 1 month</td><td align="center" valign="middle" >42</td><td align="center" valign="middle"  colspan="2"  >38.2</td></tr><tr><td align="center" valign="middle" >1 - 3 months</td><td align="center" valign="middle" >12</td><td align="center" valign="middle"  colspan="2"  >10.9</td></tr><tr><td align="center" valign="middle" >Intubation</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >79</td><td align="center" valign="middle"  colspan="2"  >71.8</td></tr><tr><td align="center" valign="middle" >1 - 7 days</td><td align="center" valign="middle" >13</td><td align="center" valign="middle"  colspan="2"  >11.8</td></tr><tr><td align="center" valign="middle" >7 days - 1 month</td><td align="center" valign="middle" >8</td><td align="center" valign="middle"  colspan="2"  >7.3</td></tr><tr><td align="center" valign="middle" >1 - 3 months</td><td align="center" valign="middle" >10</td><td align="center" valign="middle"  colspan="2"  >9.1</td></tr><tr><td align="center" valign="middle" >Hypoglycemia</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >26</td><td align="center" valign="middle"  colspan="2"  >23.6</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >84</td><td align="center" valign="middle"  colspan="2"  >76.4</td></tr><tr><td align="center" valign="middle" >Phototherapy</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >69</td><td align="center" valign="middle"  colspan="2"  >62.7</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >41</td><td align="center" valign="middle"  colspan="2"  >37.3</td></tr><tr><td align="center" valign="middle" >Maternal age (years)</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >15 - 20</td><td align="center" valign="middle" >13</td><td align="center" valign="middle"  colspan="2"  >11.8</td></tr><tr><td align="center" valign="middle" >20 - 35</td><td align="center" valign="middle" >70</td><td align="center" valign="middle"  colspan="2"  >63.6</td></tr><tr><td align="center" valign="middle" >&gt;35</td><td align="center" valign="middle" >27</td><td align="center" valign="middle"  colspan="2"  >24.6</td></tr><tr><td align="center" valign="middle" >Maternal complication</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >No complication</td><td align="center" valign="middle" >87</td><td align="center" valign="middle"  colspan="2"  >79.1</td></tr><tr><td align="center" valign="middle" >Gestational diabetes</td><td align="center" valign="middle" >11</td><td align="center" valign="middle"  colspan="2"  >10.0</td></tr><tr><td align="center" valign="middle" >Preeclampsia</td><td align="center" valign="middle" >12</td><td align="center" valign="middle"  colspan="2"  >10.9</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Characteristics of the developmental delays in the newborns</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Data</th><th align="center" valign="middle" >Number (n = 110)</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >43.6</td></tr><tr><td align="center" valign="middle" >Delayed development</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >56.4</td></tr><tr><td align="center" valign="middle" >Developmental domains:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&#183; Gross motor skills</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >47.3</td></tr><tr><td align="center" valign="middle" >&#183; Fine motor skills</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >13.6</td></tr><tr><td align="center" valign="middle" >&#183; Receptive language skills</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >14.5</td></tr><tr><td align="center" valign="middle" >&#183; Expressive language skills</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >21.8</td></tr><tr><td align="center" valign="middle" >&#183; Personal and social skills</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >12.7</td></tr></tbody></table></table-wrap><p>Our findings showed that male sex was associated with significant develop-mental delays (p = 0.017, AOR = 3.23, 95% CI = 1.24 - 8.44). Gestational age below 32 weeks was also associated with delayed development (p = 0.031, AOR = 33.35, 95% CI = 1.39 - 799.87), as was hypoglycemia (p = 0.031, AOR = 3.81, 95% CI = 1.13 - 12.85). An analysis of the maternal risk factors revealed that maternal age was associated with significant developmental delays (p = 0.022, AOR = 3.36, 95% CI = 1.19 - 9.46) (<xref ref-type="table" rid="table3">Table 3</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>In this retrospective study, the prevalence and the associated factors related to the developmental delays in high-risk newborns were analyzed. The findings showed that male sex, lower gestational age, maternal age, and hypoglycemia all contributed to various developmental delays. The prevalence of developmental delays in this study was 56.4% (62/110), with gross motor delay being the most common. In this study, all the infants with developmental delays were born with a birth weight less than 2500 grams and 22.6% (14/62) had Apgar score less than 7 at 1 minute or 5 minutes. But only 2 infants had severe birth asphyxia and developmental delays. The development of some of the newborns started to normalize after the intervention; however, 30.6% (19/62) of the infants still had developmental delays after the intervention. The incidence of developmental delays in this study was 17.2% (19/110) in those who received early intervention. In a previous study, the prevalence of developmental delays ranged from 8.76% to 28% [<xref ref-type="bibr" rid="scirp.113773-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref14">14</xref>].</p><p>Preterm birth has a significant impact on brain development, with an increased risk of the less cerebral volume of gray and white matter, and the male sex appears to be particularly vulnerable to the adverse effects of preterm birth on the development of white matter, as revealed in a previous study [<xref ref-type="bibr" rid="scirp.113773-ref15">15</xref>]. Other studies have shown that male preterm infants had more risk of developmental delay than female preterm infants [<xref ref-type="bibr" rid="scirp.113773-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref17">17</xref>]. According to the results of this study, the male sex was associated with a 3.23-times higher risk of delayed development compared to the female sex, which corresponds to the findings in previous studies [<xref ref-type="bibr" rid="scirp.113773-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref17">17</xref>].</p><p>The findings of this study revealed that preterm infants with a gestational age under 32 weeks had a significant delay in development compared to those with a gestational age over 32 weeks, which is similar to the findings of a previous study [<xref ref-type="bibr" rid="scirp.113773-ref14">14</xref>]. Studies done over the last three decades have shown that preterm infants with gestational ages ranging from 25 to 31 weeks have a higher rate of survival without neurodevelopmental impairment. However, infants with extremely low gestational age (under 25 weeks) have limited survival and morbidity remains high [<xref ref-type="bibr" rid="scirp.113773-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref5">5</xref>]. None of the newborns analyzed in this study had a gestational age of less than 25 weeks; the minimum gestational age was 25 weeks and 1 day, and the follow-up at corrected age revealed normal development.</p><p>Low birth weight infants are commonly associated with teenage pregnancies. Newborns with low birth weight have an increased risk of illness and longer hospital stay [<xref ref-type="bibr" rid="scirp.113773-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref14">14</xref>]. Maternal age of over 35 years also increases the risk of</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Factors associated with the developmental delays</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >n = 110</th><th align="center" valign="middle" >Delayed (n = 62)</th><th align="center" valign="middle" >Crude Odds Ratios</th><th align="center" valign="middle" >Adjusted Odds Ratios</th><th align="center" valign="middle" >95%CI</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >32 (66.7)</td><td align="center" valign="middle" >2.13</td><td align="center" valign="middle" >3.23</td><td align="center" valign="middle" >1.24 - 8.44</td><td align="center" valign="middle" >0.017*</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >30 (48.4)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Gestational age (weeks)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;32</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >14 (73.7)</td><td align="center" valign="middle" >2.51</td><td align="center" valign="middle" >33.35</td><td align="center" valign="middle" >1.39 - 799.87</td><td align="center" valign="middle" >0.031*</td></tr><tr><td align="center" valign="middle" >≥32</td><td align="center" valign="middle" >91</td><td align="center" valign="middle" >48 (52.7)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Birth weight (g)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;1500</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >17 (70.8)</td><td align="center" valign="middle" >2.21</td><td align="center" valign="middle" >1.13</td><td align="center" valign="middle" >0.12 - 10.54</td><td align="center" valign="middle" >0.912</td></tr><tr><td align="center" valign="middle" >1500 - 2499</td><td align="center" valign="middle" >86</td><td align="center" valign="middle" >45 (52.3)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Apgar score at 1 or 5 minutes</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;7</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >14 (58.3)</td><td align="center" valign="middle" >1.11</td><td align="center" valign="middle" >0.39</td><td align="center" valign="middle" >0.09 - 1.74</td><td align="center" valign="middle" >0.218</td></tr><tr><td align="center" valign="middle" >7 - 10</td><td align="center" valign="middle" >86</td><td align="center" valign="middle" >48 (55.8)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Maternal age (years)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;20 or &gt;35</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >28 (70.0)</td><td align="center" valign="middle" >2.47</td><td align="center" valign="middle" >3.36</td><td align="center" valign="middle" >1.19 - 9.46</td><td align="center" valign="middle" >0.022*</td></tr><tr><td align="center" valign="middle" >20 - 35</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >34 (48.6)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Maternal complications</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Gestational diabetes</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >8 (72.7)</td><td align="center" valign="middle" >2.38</td><td align="center" valign="middle" >3.20</td><td align="center" valign="middle" >0.59 - 17.47</td><td align="center" valign="middle" >0.179</td></tr><tr><td align="center" valign="middle" >Preeclampsia</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >8 (66.7)</td><td align="center" valign="middle" >1.78</td><td align="center" valign="middle" >2.23</td><td align="center" valign="middle" >0.49 - 10.26</td><td align="center" valign="middle" >0.302</td></tr><tr><td align="center" valign="middle" >No complication</td><td align="center" valign="middle" >87</td><td align="center" valign="middle" >46 (52.9)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Twins</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >20 (55.6)</td><td align="center" valign="middle" >0.95</td><td align="center" valign="middle" >1.40</td><td align="center" valign="middle" >0.51 - 3.88</td><td align="center" valign="middle" >0.516</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >74</td><td align="center" valign="middle" >42 (56.8)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Length of stay</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1 - 7 days</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >21 (47.7)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >7 days - 1 month</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >24 (57.1)</td><td align="center" valign="middle" >1.46</td><td align="center" valign="middle" >0.52</td><td align="center" valign="middle" >0.13 - 1.99</td><td align="center" valign="middle" >0.338</td></tr><tr><td align="center" valign="middle" >&gt;1 month</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >17 (70.8)</td><td align="center" valign="middle" >2.66</td><td align="center" valign="middle" >0.07</td><td align="center" valign="middle" >0.01 - 1.97</td><td align="center" valign="middle" >0.116</td></tr><tr><td align="center" valign="middle" >Intubation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >22 (71.0)</td><td align="center" valign="middle" >2.83</td><td align="center" valign="middle" >2.53</td><td align="center" valign="middle" >0.43 - 14.99</td><td align="center" valign="middle" >0.306</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >40 (50.6)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hypoglycemia</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >19 (73.1)</td><td align="center" valign="middle" >2.59</td><td align="center" valign="middle" >3.81</td><td align="center" valign="middle" >1.13 - 12.85</td><td align="center" valign="middle" >0.031*</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >43 (51.2)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Phototherapy</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >45 (65.2)</td><td align="center" valign="middle" >2.65</td><td align="center" valign="middle" >2.95</td><td align="center" valign="middle" >0.80 - 10.94</td><td align="center" valign="middle" >0.105</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >17 (41.5)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>*p &lt; 0.05; CI, confidence interval.</p><p>adverse perinatal outcomes, such as preterm birth and low birth weight [<xref ref-type="bibr" rid="scirp.113773-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref20">20</xref>]. Kortekaaset al. (2020) linked the maternal age of 20 - 35 years to positive developmental outcomes for infants. Thus, a maternal age of less than 20 years and greater than 35 years was found to be associated with a risk of delayed development in infants [<xref ref-type="bibr" rid="scirp.113773-ref19">19</xref>].</p><p>Neonatal hypoglycemia is the most common metabolic challenge in premature and low birth weight infants [<xref ref-type="bibr" rid="scirp.113773-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref22">22</xref>] and has been linked to developmental delays [<xref ref-type="bibr" rid="scirp.113773-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.113773-ref25">25</xref>], however, no research has been conducted on prevention of neonatal hypoglycemia. Early detection and treatment of neonatal hypoglycemia are therefore critical.</p><p>The findings in this study are subject to some limitations. First, only 40% of the total number of newborns included in the study had complete follow-up data; this may have an effect on the interpretation of the results in this study. Moreover, approximately 87.1% (149/171) of the newborns with birth weights between 2000 - 2500 grams were excluded from the study because they were unable to undergo the DAIM assessment in this study or had an assessment done in another healthcare facility. Data regarding this issue is not enough in this area. Every area should have such data to make a better health policy and thus we here attempted to determine factors affecting the developmental outcome in low birth weight and birth asphyxia. Second, the number of infants with Apgar at 5 minutes less than 7 was too small, not enough to interpretation. The third, hypothermia was the common and important problem of preterm infants but this study does not include these factors. Further studies could include more hospitals and long-term follow-up of cognitive development and learning difficulties. In addition, data on children with Apgar scores at 5 minutes less than 7 should be collected for further developmental outcomes. The hypothermia factors should be included in further studies.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Our findings indicated that infants with low birth weight and birth asphyxia were at a high risk of developmental delays. Furthermore, the associated risk factors included maternal age, male sex, gestational age below 32 weeks, and neonatal hypoglycemia. Thus, early detection of neonatal hypoglycemia and an early stimulation program supported by occupational therapists or trained caregivers can decrease the risk of developmental delays in these high-risk infants.</p></sec><sec id="s6"><title>Funding/Support Statement</title><p>Faculty of Medicine, Naresuan University.</p></sec><sec id="s7"><title>Acknowledgements</title><p>We thank Kornthip Jeephet for statistical analysis and Dusadee Sunthornpongnark for Figurepreparation. We would like to thank the Faculty of Medicine, Naresuan University for permission to collect the data.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Weerakul, J., Sanjaiban, M. and Intasen, S. (2021) Factors Affecting the Developmental Outcomes of High-Risk Newborns. Open Journal of Pediatrics, 11, 749-758. https://doi.org/10.4236/ojped.2021.114069</p></sec></body><back><ref-list><title>References</title><ref id="scirp.113773-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2018) International Statistical Classification of Diseases and Related Health Problems, 11th Revision. World Health Organization, Geneva. https://www.who.int/standards/classifications/classification-of-diseases</mixed-citation></ref><ref id="scirp.113773-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Gebregzabiherher, Y., Haftu, A., Weldemariam, S. and Gebrehiwet, H. (2017) The Prevalence and Risk Factors for Low Birth Weight among Term Newborns in Adwa General Hospital, Northern Ethiopia. Obstetrics and Gynecology International, 2017, Article ID: 2149156. https://doi.org/10.1155/2017/2149156</mixed-citation></ref><ref id="scirp.113773-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Yinager, W., Ayele, S., Emiru, A., Worku, A., Mulat, T. and Minychil B. (2020) Prevalence of Perinatal Asphyxia in East and Central Africa: Systematic Review and Meta-Analysis. Heliyon, 6, Article No. e03793.  
https://doi.org/10.1016/j.heliyon.2020.e03793</mixed-citation></ref><ref id="scirp.113773-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Myrhaug, H.T., Brurberg, K.G., Hov, L.T. and Markestad, T. (2019) Survival and Impairment of Extremely Premature Infants: A Meta-Analysis. Pediatrics, 143, Article ID: e20180933. https://doi.org/10.1542/peds.2018-0933</mixed-citation></ref><ref id="scirp.113773-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Wang, L.W., Lin, Y.C., Wang, S.T. and Huang, C.C. (2021) Trends in Survival, Neonatal Morbidity, and Neurodevelopmental Outcome of Very Preterm Infants in Tainan, Southern Taiwan, 1995-2016. Journal of the Formosan Medical Association, 120, 1314-1323. https://doi.org/10.1016/j.jfma.2020.12.025</mixed-citation></ref><ref id="scirp.113773-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Kumar, N. and Yadav, A. (2019) Preterm Birth and Perinatal Outcome: An Observational Cohort Study. Medical Science Pulse, 13, 4-10.  
https://doi.org/10.5604/01.3001.0013.7370</mixed-citation></ref><ref id="scirp.113773-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Ward, R.M. and Beachy, J.C. (2003) Neonatal Complications Following Preterm Birth. BJOG, 110, 8-16.</mixed-citation></ref><ref id="scirp.113773-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Soleimani, F., Vameghi, R., Hemmati, S. and Salman-Roghani, R. (2009) Perinatal and Neonatal Risk Factors for Neurodevelopmental Outcome in Infants in Karaj. Archives of Iranian Medicine, 12, 135-139.</mixed-citation></ref><ref id="scirp.113773-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Agarwal, P.K., Yang, P.H., Daniel, L.M., Shi, L., Zheng, Q. and Rajadurai, V.S., et al. (2018) Factors Affecting Neurodevelopmental Outcome at 2 Years in Very Preterm Infants below 1250 Grams: A Prospective Study. Journal of Perinatology, 38, 1093-1100.  
https://doi.org/10.1038/s41372-018-0138-3</mixed-citation></ref><ref id="scirp.113773-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Pitsawong, C. and Panichkul, P. (2011) Risk Factors Associated with Birth Asphyxia in Phramongkutklao Hospital. Thai Journal Obstetrics and Gynaecology, 19, 165-171.</mixed-citation></ref><ref id="scirp.113773-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Lawn, J.E., Cousens, S. and Zupan, J. (2005) 4 Million Neonatal Deaths: When? Where? Why? Lancet, 365, 891-900.  
https://doi.org/10.1016/S0140-6736(05)71048-5</mixed-citation></ref><ref id="scirp.113773-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Phunsawat, R. (2016) A Pilot Study to Compare DAIM (Developmental Assessment for Intervention Manual) and DENVER II in Children Aged 4 Months, 9 Months and 12 Months. Dissertation, Queen Sirikit National Institute of Child Health, Bangkok.</mixed-citation></ref><ref id="scirp.113773-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Lin, C.-Y., Hsu, C.-H. and Chang, J.-H. (2020) Neurodevelopmental Outcomes at 2 and 5 Years of Age in Very-Low-Birth-Weight Preterm Infants Born between 2002 and 2009: A Prospective Cohort Study in Taiwan. Pediatrics &amp; Neonatology, 61, 36-44. https://doi.org/10.1016/j.pedneo.2019.05.006</mixed-citation></ref><ref id="scirp.113773-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Sudhir, U., Ghanghoriya, P., Barman, M. and Joshi, T. (2017) Growth and Neurodevelopmental Outcome of High-Risk Premature Neonates at 1 Year in a Tertiary Level NICU of Central India. International Journal of Contemporary Pediatrics, 4, 1787-1791. https://doi.org/10.18203/2349-3291.ijcp20173786</mixed-citation></ref><ref id="scirp.113773-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Reiss, A.L., Kesler, S.R., Vohr, B., Duncan, C.C, Katz, K.H. and Pajot. S, et al. (2004) Sex Differences in Cerebral Volumes of 8-Year-Old Born Preterm. The Journal of Pediatrics, 145, 242-249. https://doi.org/10.1016/j.jpeds.2004.04.031</mixed-citation></ref><ref id="scirp.113773-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Hintz, S.R., Kendrick, D.E., Vohr, B.R., Kenneth Poole, W. and Higgins, R.D. (2006) Gender Differences in Neurodevelopmental Outcomes among Extremely Preterm, Extremely-Low-Birthweight Infants. Acta Paediatrica, 95, 1239-1248.  
https://doi.org/10.1080/08035250600599727</mixed-citation></ref><ref id="scirp.113773-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Nam, Y.S., Heo, J.S., Byeon, J.H. and Lee, E.H. (2020) Neurodevelopmental Outcomes of Moderate-to-Late Preterm Infants. Neonatal Medicine, 27, 159-166.  
https://doi.org/10.5385/nm.2020.27.4.159</mixed-citation></ref><ref id="scirp.113773-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Anne, H.W. (1999) Identification and Treatment of Risk Factors in Newborns and Infants in the United States. Enfance, No. 1, 79-91.  
https://doi.org/10.3406/enfan.1999.3132</mixed-citation></ref><ref id="scirp.113773-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Kortekaas, J.C., Kazemier, B.M., Keulen, J.K.J., Bruinsma, A., Mol, B.W. and Vandenbussche, F., et al. (2020) Risk of Adverse Pregnancy Outcomes of Late- and Post-term Pregnancies in Advanced Maternal Age: A National Cohort Study. Acta Obstetricia et Gynecologica Scandinavica, 99, 1022-1030. 
https://doi.org/10.1111/aogs.13828</mixed-citation></ref><ref id="scirp.113773-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Pinheiro, R.L., Areia, A.L., Mota Pinto, A. and Donato H. (2019) Advanced Maternal Age: Adverse Outcomes of Pregnancy: A Meta-Analysis. Acta Médica Portuguesa, 32, 219-226. https://doi.org/10.20344/amp.11057</mixed-citation></ref><ref id="scirp.113773-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Saw, H.-P., Yao, N.-W., Chiu, C.-D. and Chen J.-Y. (2017) The Value of Real-Time Continuous Glucose Monitoring in Premature Infants of Diabetic Mothers. PLoS ONE, 12, Article ID: e0186486. https://doi.org/10.1371/journal.pone.0186486</mixed-citation></ref><ref id="scirp.113773-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Ramzan, M., Razzaq, A. and Kiyani, A.N. (2017) Hypoglycemia in Small for Gestation Age Neonates Based on Gestational Age, Gender, Birth Weight and Mode of Delivery. Pakistan Armed Forces Medical Journal, 67, 397-400.</mixed-citation></ref><ref id="scirp.113773-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Stomnaroska, O., Dukovska, V. and Danilovski, D. (2020) Neurodevelopmental Consequences of Neonatal Hypoglycemia. Prilozi, 41, 89-93.  
https://doi.org/10.2478/prilozi-2020-0037</mixed-citation></ref><ref id="scirp.113773-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Wickstr&amp;ouml;m, R., Ski&amp;ouml;ld, B., Petersson, G., Stephansson, O. and Altman, M. (2008) Moderate Neonatal Hypoglycemia and Adverse Neurological Development at 2-6 Years of Age. European Journal of Epidemiology, 33, 1011-1020.  
https://doi.org/10.1007/s10654-018-0425-5</mixed-citation></ref><ref id="scirp.113773-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Adamkin, D.H. (2017) Neonatal Hypoglycemia. Seminars in Fetal &amp; Neonatal Medicine, 22, 36-41. https://doi.org/10.1016/j.siny.2016.08.007</mixed-citation></ref></ref-list></back></article>